Home | Business Weekly
Oct 24, 2024 · Cambridge life science & technology company deals hit $22.5bn in 12 months. Cambridge life science and technology companies have been involved in a dizzying series of acquisitions and fundraisings collectively worth more than $22.558 billion in the last 12 months (to October 16, 2024).
Parkwalk leads £4m investment in Psyomics - Business Weekly
Jun 10, 2024 · Parkwalk leads £4m investment in Psyomics. 10 Jun, 2024. Tony Quested. Cambridge-based mental HealthTech company Psyomics has raised £4 million growth capital, with Parkwalk Advisors contributing £3.5 million as lead investor. Psyomics CEO, Dr Melinda Rees. Credit – Psyomics.
Cambridge on song as ARIA orchestrates brain health revolution
Oct 8, 2024 · Cambridge on song as ARIA orchestrates brain health revolution. A large cohort spanning the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK Government’s new research funding agency.
New home for Cambridge Science Centre - Business Weekly
Jun 2, 2024 · John Bull, CEO, Cambridge Science Centre, said: “We are excited to be opening the doors to our new space within Cambridge Science Park in July 2024. This new location feels like our spiritual home; it further strengthens our connections with the STEM ecosystem and brings communities to the very heart of science and technology in Cambridge.
UK, US and European investment as Acteon is acquired
Mar 26, 2024 · UK, US and European investment as Acteon is acquired. 26 Mar, 2024. Newsdesk. Norwich-anchored Acteon Group, a global offshore energy infrastructure services business, has been acquired by private equity investors Buckthorn Partners and One Equity Partners (OEP). No figures have been disclosed for the international deal. Courtesy – …
From £8m to more than £100m and NetScientific becomes EMV …
Sep 25, 2024 · From £8m to more than £100m and NetScientific becomes EMV Capital. AIM-quoted NetScientific Plc, a DeepTech and life sciences VC investment group with Cambridge facilities, has changed its name to EMV Capital plc. Dr Ilian Iliev. Courtesy – EMV Capital. The rebrand marks the culmination of NetScientific’s strategic evolution, since ...
New powerhouse created to advance Cell and Gene Therapy …
May 28, 2024 · A Cambridge-Stevenage pact is set to transform the automation of cell and gene therapies. Working together on the project are Cambridge's Cellular Origins, a TTP company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies, and the Cell and Gene Therapy Catapult – a Stevenage-based independent innovation and technology organisation specialising in ...
New Emirates lounge ‘takes off’ at Stansted
22 Sep, 2024. Newsdesk. Emirates has opened the doors to its new lounge at London Stansted Airport. The airline has invested more than £4 million to design a spacious 900-square-metre lounge that can accommodate up to 125 guests, including First and Business Class customers, as well as Emirates Skywards members. Emirates’ lounge at Stansted.
Timely $5.3 million helps clock.bio boost rejuvenation roadmap
Oct 8, 2024 · Timely $5.3 million helps clock.bio boost rejuvenation roadmap. 08 Oct, 2024. Tony Quested. Cambridge-based clock.bio, a healthspan biotech working to reverse ageing, has raised $5.3 million seed funding led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures and serial Cambridge life science entrepreneur Dr Jonathan Milner.
Mestag Therapeutics lines up potential $1.9bn haul from MSD
Oct 8, 2024 · Mestag Therapeutics lines up potential $1.9bn haul from MSD. Mestag Therapeutics, a Cambridge biotech harnessing new insights into fibroblast-immune interactions, has entered into a license and collaboration agreement with MSD (tradename of Merck & Co., Inc) to identify novel targets for the development of therapies against inflammatory diseases.